glp-1 and cancer Receptor Agonists: Benefits Risks in Colorectal Glucagon-like peptide 1 receptor agonists

UCP2, a member of the mitochondrial uncoupling proteins: an overview from physiological to pathological roles

Thymosin Beta-4 modulates COX-2 expression affecting prostaglandin production

GPNA can inhibit ASCT2 and other glutamine transporters, such as sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, large neutral amino acid transporter 1 (LAT1), and LAT2, leading to decreased uptake of essential amino acids (Freidman et al., 2022)

The study on glutathione in patients with chronic alcoholic liver disease treated patients with 1800mg/day glutathione intravenously for 10 days, followed by 600mg of glutathione intramuscularly every day for 20 days

If a wellness brand is positioning it as any of those things, that brand is selling you a story the trial literature does not support